Works matching IS 10837159 AND DT 2018 AND VI 23

Results: 259
    1
    2
    3
    4
    5
    6
    7
    8

    Modulation of Premetastatic Niche by the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Localized High‐Risk Prostate Cancer Followed by Radical Prostatectomy: A Phase II Randomized Trial.

    Published in:
    Oncologist, 2018, v. 23, n. 12, p. 1413, doi. 10.1634/theoncologist.2018-0652
    By:
    • Maughan, Benjamin L.;
    • Pal, Sumanta K.;
    • Gill, David;
    • Boucher, Kenneth;
    • Martin, Christopher;
    • Salgia, Meghan;
    • Nussenzveig, Roberto;
    • Liu, Ting;
    • Hawks, Josiah L.;
    • Batten, Julia;
    • Nachaegari, Gayatri;
    • Stephenson, Robert;
    • Lowrance, William;
    • Jones, Jeremy;
    • Dechet, Christopher;
    • Agarwal, Neeraj
    Publication type:
    Article
    9

    In Reply.

    Published in:
    2018
    By:
    • Dang, Chau T.;
    • Singh, Jasmeet C.;
    • Steingart, Richard M.;
    • Yu, Anthony F.
    Publication type:
    Letter to the Editor
    10

    Randomized, Open‐Label Phase II Study Comparing Capecitabine‐Cisplatin Every 3 Weeks with S‐1‐Cisplatin Every 5 Weeks in Chemotherapy‐Naïve Patients with HER2‐Negative Advanced Gastric Cancer: OGSG1105, HERBIS‐4A Trial

    Published in:
    Oncologist, 2018, v. 23, n. 12, p. 1411, doi. 10.1634/theoncologist.2018-0175
    By:
    • Kawakami, Hisato;
    • Takeno, Atsushi;
    • Endo, Shunji;
    • Makari, Yoichi;
    • Kawada, Junji;
    • Taniguchi, Hirokazu;
    • Tamura, Shigeyuki;
    • Sugimoto, Naotoshi;
    • Kimura, Yutaka;
    • Tamura, Takao;
    • Fujitani, Kazumasa;
    • Sakai, Daisuke;
    • Shimokawa, Toshio;
    • Kurokawa, Yukinori;
    • Satoh, Taroh
    Publication type:
    Article
    11

    Durable Response to Nivolumab in a Pediatric Patient with Refractory Glioblastoma and Constitutional Biallelic Mismatch Repair Deficiency.

    Published in:
    Oncologist, 2018, v. 23, n. 12, p. 1401, doi. 10.1634/theoncologist.2018-0163
    By:
    • AlHarbi, Musa;
    • Ali Mobark, Nahla;
    • AlMubarak, Latifa;
    • Aljelaify, Rasha;
    • AlSaeed, Mariam;
    • Almutairi, Amal;
    • Alqubaishi, Fatmah;
    • Hussain, M. Emarat;
    • Balbaid, Ali Abdullah O.;
    • Said Marie, Amal;
    • AlSubaie, Lamia;
    • AlShieban, Saeed;
    • alTassan, Nada;
    • Ramkissoon, Shakti H.;
    • Abedalthagafi, Malak
    Publication type:
    Article
    12
    13
    14
    15

    A Phase I Dose‐Escalation Study of Linsitinib (OSI‐906), a Small‐Molecule Dual Insulin‐Like Growth Factor‐1 Receptor/Insulin Receptor Kinase Inhibitor, in Combination with Irinotecan in Patients with Advanced Cancer.

    Published in:
    Oncologist, 2018, v. 23, n. 12, p. 1409, doi. 10.1634/theoncologist.2018-0315
    By:
    • Davis, S. Lindsey;
    • Eckhardt, S. Gail;
    • Diamond, Jennifer R.;
    • Messersmith, Wells A.;
    • Dasari, Arvind;
    • Weekes, Colin D.;
    • Lieu, Christopher H.;
    • Kane, Madeline;
    • Choon Tan, Aik;
    • Pitts, Todd M.;
    • Leong, Stephen
    Publication type:
    Article
    16
    17
    18

    In Reply.

    Published in:
    2018
    By:
    • Durani, Urshila;
    • Go, Ronald S.
    Publication type:
    Letter to the Editor
    19
    20
    21
    22
    23

    In the Patient's Shoes.

    Published in:
    Oncologist, 2018, v. 23, n. 12, p. 1546, doi. 10.1634/theoncologist.2017-0525
    By:
    • Coradazzi, Ana Lucia
    Publication type:
    Article
    24

    Machine Learning for Better Prognostic Stratification and Driver Gene Identification Using Somatic Copy Number Variations in Anaplastic Oligodendroglioma.

    Published in:
    Oncologist, 2018, v. 23, n. 12, p. 1500, doi. 10.1634/theoncologist.2017-0495
    By:
    • Rosenberg, Shai;
    • Ducray, Francois;
    • Alentorn, Agusti;
    • Dehais, Caroline;
    • Elarouci, Nabila;
    • Kamoun, Aurelie;
    • Marie, Yannick;
    • Tanguy, Marie‐Laure;
    • De Reynies, Aurélien;
    • Mokhtari, Karima;
    • Figarella‐Branger, Dominique;
    • Delattre, Jean‐Yves;
    • Idbaih, Ahmed;
    • Desenclos, C.;
    • Sevestre, H.;
    • Menei, P.;
    • Rousseau, A.;
    • Cruel, T.;
    • Lopez, S.;
    • Mihai, M‐I
    Publication type:
    Article
    25

    Cluster Analysis Demonstrates the Need to Individualize Care for Cancer Survivors.

    Published in:
    Oncologist, 2018, v. 23, n. 12, p. 1474, doi. 10.1634/theoncologist.2017-0558
    By:
    • de Rooij, Belle H.;
    • Park, Elyse R.;
    • Perez, Giselle K.;
    • Rabin, Julia;
    • Quain, Katharine M.;
    • Dizon, Don S.;
    • Post, Kathryn E.;
    • Chinn, Garrett M.;
    • McDonough, Allison L.;
    • Jimenez, Rachel B.;
    • van de Poll‐Franse, Lonneke V.;
    • Peppercorn, Jeffrey
    Publication type:
    Article
    26
    27

    Prognostic Nomogram Based on Histological Characteristics of Fibrotic Tumor Stroma in Patients Who Underwent Curative Resection for Intrahepatic Cholangiocarcinoma.

    Published in:
    Oncologist, 2018, v. 23, n. 12, p. 1482, doi. 10.1634/theoncologist.2017-0439
    By:
    • Jing, Chu‐Yu;
    • Fu, Yi‐Peng;
    • Huang, Jin‐Long;
    • Zhang, Mei‐Xia;
    • Yi, Yong;
    • Gan, Wei;
    • Xu, Xin;
    • Shen, Hu‐Jia;
    • Lin, Jia‐Jia;
    • Zheng, Su‐Su;
    • Zhang, Juan;
    • Zhou, Jian;
    • Fan, Jia;
    • Ren, Zheng‐Gang;
    • Qiu, Shuang‐Jian;
    • Zhang, Bo‐Heng
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34

    Volume 23 Acknowledgments.

    Published in:
    Oncologist, 2018, v. 23, n. 12, p. e179, doi. 10.1634/theoncologist.2018-r000
    Publication type:
    Article
    35
    36

    Comparative Effectiveness of an mTOR‐Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple‐Negative Breast Cancer.

    Published in:
    Oncologist, 2018, v. 23, n. 11, p. 1300, doi. 10.1634/theoncologist.2017-0498
    By:
    • Basho, Reva K.;
    • Yam, Clinton;
    • Gilcrease, Michael;
    • Murthy, Rashmi K.;
    • Helgason, Thorunn;
    • Karp, Daniel D.;
    • Meric‐Bernstam, Funda;
    • Hess, Kenneth R.;
    • Valero, Vicente;
    • Albarracin, Constance;
    • Litton, Jennifer K.;
    • Chavez‐MacGregor, Mariana;
    • Hong, David;
    • Kurzrock, Razelle;
    • Hortobagyi, Gabriel N.;
    • Janku, Filip;
    • Moulder, Stacy L.
    Publication type:
    Article
    37
    38

    Volume 23 Author Index.

    Published in:
    Oncologist, 2018, v. 23, n. 12, p. e167, doi. 10.1634/theoncologist.2018-a000
    Publication type:
    Article
    39
    40
    41

    Single‐Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial).

    Published in:
    Oncologist, 2018, v. 23, n. 11, p. 1271, doi. 10.1634/theoncologist.2018-0316
    By:
    • García‐Alfonso, Pilar;
    • Benavides, Manuel;
    • Falcó, Esther;
    • Muñoz, Andrés;
    • Gómez, Auxiliadora;
    • Sastre, Javier;
    • Rivera, Fernando;
    • Montagut, Clara;
    • Salgado, Mercedes;
    • López‐Ladrón, Amelia;
    • López, Rafael;
    • Ruiz de Mena, Inmaculada;
    • Durán, Gema;
    • Aranda, Enrique
    Publication type:
    Article
    42
    43
    44

    Association of Immune‐Related Adverse Events with Clinical Benefit in Patients with Advanced Non‐Small‐Cell Lung Cancer Treated with Nivolumab.

    Published in:
    Oncologist, 2018, v. 23, n. 11, p. 1358, doi. 10.1634/theoncologist.2017-0384
    By:
    • Toi, Yukihiro;
    • Sugawara, Shunichi;
    • Kawashima, Yosuke;
    • Aiba, Tomoiki;
    • Kawana, Sachiko;
    • Saito, Ryohei;
    • Tsurumi, Kyoji;
    • Suzuki, Kana;
    • Shimizu, Hisashi;
    • Sugisaka, Jun;
    • Ono, Hirotaka;
    • Domeki, Yutaka;
    • Terayama, Keisuke;
    • Nakamura, Atsushi;
    • Yamanda, Shinsuke;
    • Kimura, Yuichiro;
    • Honda, Yoshihiro
    Publication type:
    Article
    45
    46
    47
    48

    Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer‐Associated Thrombosis: The Observational ROADMAP‐CAT Study.

    Published in:
    Oncologist, 2018, v. 23, n. 11, p. 1372, doi. 10.1634/theoncologist.2017-0530
    By:
    • Syrigos, Konstantinos;
    • Grapsa, Dimitra;
    • Sangare, Rabiatou;
    • Evmorfiadis, Ilias;
    • Larsen, Annette K.;
    • Van Dreden, Patrick;
    • Boura, Paraskevi;
    • Charpidou, Andriani;
    • Kotteas, Elias;
    • Sergentanis, Theodoros N.;
    • Elalamy, Ismail;
    • Falanga, Anna;
    • Gerotziafas, Grigoris T.
    Publication type:
    Article
    49
    50